Pages
- Adcirca® (Tadalafil)
- Ambrisentan (Letaris™)
- Ampule
- Angina
- Aorta
- Arrhythmia
- Arterial blood gas - ABG
- Atrial fibrillation & atrial flutter
- Atrial Septal Defect (ASD)
- Atrium
- BiPAP - Bi-level Positive Air Pressure
- C-PAP - Continous Positive Air Pressure
- Calcium Channel Blocker - CCB
- Cardiac output
- Catheter
- Catheterization
- Central line catheter
- Central Sleep Apnea
- Clinical trials
- Constrict
- COPD
- CREST syndrome
- Cyanosis
- Diastolic pressure
- Dilate
- Diluent
- Dual ERA
- Dyspnea
- Echocardiogram
- Edema
- Endothelial cells
- Endothelin
- Endothelin receptor antagonist (ETRA)
- Endothelin receptors
- Endothelium
- EPAP (exhalation positive air pressure)
- FDA
- Fibrosis
- Flolan
- Gas Exchange
- Heartbeat
- Hyperactive
- Hypertension
- Hypotension
- Hypoxia
- INR
- IPAP (inhalation positive air pressure)
- Lung volume
- Mean blood pressure
- Nuclear testing
- NYHA Class I - IV
- O2
- Obstructive Sleep Apnea
- Oximeter
- Oxygen saturation
- PAH
- Palpitation
- PCP
- PH Specialist
- Primary pulmonary hypertension - PPH
- Prostacyclin
- Prostaglandin
- Pulmonary
- Pulmonary arterial hypertension - PAH
- Pulmonary artery - PA
- Pulmonary Artery Pressure - PAP
- Pulmonary Function Test – PFT
- Pulmonary Hypertension - (PH)
- Pulse oximeter
- Remodulin™
- Revatio (Sildenafil)
- RHC - Right Heart Catheterizations
- Scleroderma
- Secondary pulmonary hypertension - SPH
- Selective ERA
- Sildenafil (Revatio™, Viagra™)
- Sitaxsentan
- Sleep Apnea
- Sleep Mask
- Smooth muscle
- SOB
- Specialty pharmacy distributor
- Subcutaneous infusion
- Syncope
- Systemic
- Systolic pressure
- Tadalafil (Adcirca®)
- Targeted ERAs
- Thoracentesis
- Tracleer™ (formerly Bosentan)
- Treprostinil
- UT-15
- Vasoconstrictor
- Vasodilator
- Ventricle
- Ventricular Septal Defect (VSD)
- Viagra™ (Sildenafil)
NYHA Class I - IV
New York Heart Association functional classification. An assessment of physical limitations and symptoms of patients with heart disease. This classification system has been modified slightly by the WHO World Symposium on PH to describe pulmonary hypertension patients. Briefly stated:
- Class I: Patients with pulmonary hypertension but without resulting limitation of physical activity. Ordinary physical activity does not cause undue dyspnea or fatigue, chest pain or near syncope.
- Class II: slight limitation of physical activity. They are comfortable at rest. Ordinary physical activity causes undue dyspnea or fatigue, chest pain or near syncope.
- Class III: marked limitation of physical activity. They are comfortable at rest. Less than ordinary physical activity causes undue dyspnea or fatigue, chest pain or near syncope.
- Class IV: inability to carry out any physical activity without symptoms. These patients manifest signs of right heart failure. Dyspnea and/or fatigue may even be present at rest. Discomfort is increased by any physical activity.

.jpg)